Related Experiment Video
Updated: Jan 20, 2026

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Published on: February 4, 2021
Targeting the Sanctuary Site: Options when Breast Cancer Metastasizes to the Brain
Abstract:
Brain metastasis is a poor prognostic factor in breast cancer progression, and traditional treatment options have shown minimal response with overall low median survival rates. The incidence of brain metastasis has been increasing despite and, in part, due to advancements in treatment as a result of prolongation of survival. Targeted therapy such anti-HER2 agents have a lower efficacy in this setting compared to metastases elsewhere; however, novel therapies are emerging in this regard. In this comprehensive review, we discuss risk per subtype, special considerations for therapy selection, current focal and systemic treatments, and recent advancements and potential future targets for success. We present our treatment paradigm and multidisciplinary approach to brain metastases arising from breast cancer based on the available evidence, incorporating molecular characteristics.
Insights
Brain metastases significantly worsen breast cancer prognosis, with limited treatment success. This review covers risk, current therapies, and emerging strategies for improved outcomes in breast cancer brain metastases.
Area of Science:
- Oncology
- Neurology
- Cancer Research
Background:
- Brain metastasis is a critical challenge in advanced breast cancer, associated with poor prognosis and low survival rates.
- Increasing survival due to treatment advancements paradoxically leads to a higher incidence of brain metastases.
- Established treatments, including anti-HER2 agents, show limited efficacy against brain metastases compared to other sites.
Purpose of the Study:
- To provide a comprehensive review of breast cancer brain metastases.
- To discuss risk factors, therapeutic selection, and current/emerging treatments.
- To present a multidisciplinary treatment paradigm incorporating molecular characteristics.
Main Methods:
- Literature review of current evidence on breast cancer brain metastases.
- Analysis of risk factors stratified by breast cancer subtype.
- Evaluation of focal and systemic treatment options and novel therapeutic targets.
Main Results:
- Breast cancer brain metastases represent a significant clinical challenge with poor outcomes.
- Novel therapies are emerging, offering potential improvements over traditional treatments.
- Understanding molecular characteristics is crucial for effective treatment selection.
Conclusions:
- A multidisciplinary approach integrating molecular insights is essential for managing breast cancer brain metastases.
- Further research into novel therapies and targets is critical to improve patient survival and quality of life.
- Personalized treatment strategies are key to overcoming the challenges posed by brain metastases in breast cancer.
Related Concept Videos
05:02Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
09:48Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
08:36Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
10:38An Ex Vivo Brain Slice Model to Study and Target Breast Cancer Brain Metastatic Tumor Growth
09:29Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

